Hetmos structures financing for acquisition programs and growth plans, combining investor access, funding architecture, and execution support across debt and equity.
Scope
Capital strategy designed for transactions, scale, and closing certainty.
Our financing work combines fundraise preparation, partner outreach, and acquisition-oriented structuring so capital moves in step with the operating and M&A agenda.
IPO Specialist
Christian Finan leads Hetmos's IPO and capital markets execution platform for growth-company financings.
With more than two decades in equity capital markets, Christian advises growth SMEs and mid-sized companies on how to access public and private financing with the right structure, sequencing, and market positioning. He works directly with founders, CEOs, and shareholders on financing paths that support expansion, acquisition programs, shareholder reorganizations, and time-sensitive balance-sheet transitions.
As an accredited Euronext Listing Sponsor for Growth and Access in Paris and Brussels, he brings end-to-end execution support across pre-IPO preparation, equity story framing, documentation, regulator and exchange coordination, investor process management, and roadshow sequencing. His mandates also extend to private placements, capital increases, convertible and straight debt structures, post-listing support, and delisting situations when public markets no longer fit the company's strategy.
His work is particularly relevant for healthcare, biotech, medtech, technology, and other innovation-led sectors where investor credibility, valuation discipline, and transaction timing materially affect outcomes. The operating principle remains straightforward: keep the financing route aligned with the company’s long-term agenda while managing counterparties, market windows, and execution pressure with precision.
- IPOs and pre-IPO preparationPreparation for Euronext Access, Growth, and regulated market listings, with coordinated execution from positioning to admission.
- Private placements, debt, and hybridsEquity, bank debt, convertible instruments, and bespoke financing structures matched to growth and acquisition needs.
- Post-listing and follow-on situationsCapital increases, secondary placements, investor positioning work, and follow-through once a company is public.
- Delistings and strategic capital structuringSupport on public-to-private paths, recapitalizations, and broader capital architecture decisions around corporate strategy.
Offer Stack
01
Hetcap – Fundraising & Financial Structuring
Preparation of investment-grade materials, selective outreach to funds and family offices, and negotiation support through funding close.
02
Acquisition & Growth Financing
Debt and equity frameworks tailored to buy-and-build plans, recapitalizations, and expansion initiatives with controlled downside risk.
03
Hetlodge – Co-Investment Pathways
Aligned co-investment and operator support models for entrepreneurs building equity positions through structured acquisition programs.
Execution Principles
-
Actionable Financial Engineering
Financing design is built around execution constraints, not presentation theory, so resources can be deployed quickly.
-
Selective Investor Access
Outreach is concentrated on capital partners whose mandate, ticket size, and timeline match the transaction profile.
-
Integrated Deal Timing
Capital workstreams are synchronized with legal, commercial, and diligence milestones to prevent execution drift.
-
Terms and Certainty Balance
We optimize funding around valuation impact, covenant flexibility, and close reliability across market cycles.
References
Selected transactions across IPOs, capital raises, privatizations, debt financing, and listed-company M&A, executed in France and international markets.
Initial Public Offerings
Advisory on IPO execution for growth companies and international issuers.
- Aufeminin.com
- Beaconsmind GmbH
- Bone Therapeutics
- DBV Technologies
- Egide
- Erytech Pharma
- Esker
- Galapagos
- Gameloft
- Hologram Industries
- Infotel
- Innate Pharma
- LDR Holdings
- McPhy Energy
- The Azur Selection
- Toosla
- Voltalia
- Zealand Pharma
Capital Raises and Shareholding Restructurings
Structuring and execution of balance-sheet reinforcement, refinancing, and shareholding transition transactions.
- Ablynx
- BioAlliance Pharma (Onxeo)
- Coldway
- DBV Technologies
- Erytech Pharma
- ESR
- Havas
- HDS Group
- Lafarge Holcim
- LDR Holdings
- Mauna Kea
- McPhy Energy
- Parrot
- Risc Groupe
- Sword Group
- Theradiag
- Transgene
- Yaqrit Ltd.
Privatizations
Execution support on privatization transactions and strategic public ownership transitions.
- Bull
- Air France
- Thomson Multimedia
- ASF (Autoroutes du Sud de la France)
Convertible/Straight Bonds and Bank Financing
Structuring and placement of bond and bank financing, including senior and tailored debt solutions.
- Club Med
- GoADV
- Havas
- IPSOS
- LogicaCMG
- Menissez
- PPR (Kering)
- Saint-Gobain
- Souriau
- Terreal
- Vivendi
Listed-company M&A, Mergers, and Delistings
Advisory on strategic combinations and delisting processes involving international acquirers and sponsors.
- Axway / Systar
- Boston Scientific / Symetis
- Carlyle / Metrologic
- Naxicap / Softway Medical
- Osiatis / ESR
- PROS / Cameleon Software
- Santen Pharma / Novagali Pharma
- Thoma Bravo / Infovista


























































